![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Tuesday, July 19, 2011 10:42:28 PM
Doing some more research and have decided that it is more compelling to compare LaViv to Provenge (rather than Botox).
Seeking Alpha was onto this last month, but I somehow missed the comparison.
http://seekingalpha.com/news-article/1317401-fibrocell-s-laviv-gets-nod-in-lucrative-aesthetics-market
The parallels between Dendreon and Fibrocell are striking and IMO serve for better comparison. In the two years since approval DNDN has gone from $3 to over $30. We may not see our profit immediately but it will pay off to those of us who have patience.
Cannabix Technologies and Omega Laboratories Inc. Provide Positive Developments on Marijuana Breathalyzer Testing • BLO • Jul 11, 2024 8:21 AM
ECGI Holdings Enhances Board with Artificial Intelligence (AI) Expert Ahead of Allon Apparel Launch • ECGI • Jul 10, 2024 8:30 AM
Avant Technologies to Meet Unmet Needs in AI Industry While Addressing Sustainability Concerns • AVAI • Jul 10, 2024 8:00 AM
Panther Minerals Inc. Launches Investor Connect AI Chatbot for Enhanced Investor Engagement and Lead Generation • PURR • Jul 9, 2024 9:00 AM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM